At Vitestro, we are developing a medical robotics device that has the potential to touch the lives of a billion patients. We collaborate with leading hospitals and clinical laboratories. We are committed to build a leading medical robotics company that will have a great impact on patient care.
www.vitestro.com
www.vitestro.com
Location: Netherlands
Employees: 11-50
Total raised: $104.92M
Founded date: 2017
Investors 1
| Date | Name | Website |
| 10.03.2024 | Sonder Cap... | sondercapi... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.03.2026 | Series B | $70M | European I... |
| 30.04.2024 | - | $22M | - |
| 22.03.2023 | Series A | $12.92M | - |
Mentions in press and media 15
| Date | Title | Description |
| 11.03.2026 | Vitestro Secures $70 Million to Revolutionize Blood Collection | Vitestro secured $70 million in Series B funding. This capital fuels autonomous robotic blood collection. The Aletta system automates venipuncture with AI, multimodal imaging, and robotics. It aims for precise, consistent blood draws. This ... |
| 10.03.2026 | Vitestro: $70 Million Raised To Advance Autonomous Robotic Blood Collection Technology | Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of its robotic phlebotomy platform and exp... |
| 10.03.2026 | Vitestro Raises $70M in Series B Funding | Vitestro, a Utrecht, the Netherlands-based medical robotics company, raised $70M in Series B funding. Backers included Labcorp Venture Fund, Mayo Clinic, and Sutter Health, new financial investors InterVest, MGFO, PGGM, Puma Venture Capital... |
| 21.03.2025 | Health | Would you let a robot draw your blood? Health systems trying new device | Unlike with a traditional blood draw, the patient does not see the needle go into the arm nor the tubes of blood. The entire process takes about two minutes. “With this device they never see the needle and and they never see or experience o... |
| 01.05.2024 | Vitestro Revolutionizes Blood Draws with $22M Funding Boost | Vitestro, the autonomous blood drawing company, secures $22 million to accelerate commercialization of its innovative robotic device. The funding round, led by Sonder Capital and NYBC Ventures, aims to drive European expansion and U.S. mark... |
| 30.04.2024 | Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device | - |
| 30.04.2024 | Dutch startup Vitestro raises €20M to accelerate commercialisation of its robotic blood drawing device | Read this article in: Utrecht-based Vitestro, a company specialised in autonomous blood drawing technology, announced on Tuesday that it has secured $22M (approximately €20M) funding, bringing the total raised to $50M (approximately €46M) f... |
| 30.04.2024 | Autonomous blood drawing device developer Vitestro raises $22M | The company plans to bring its device to market in Europe before expanding to the United States Blood draws are one of the most common invasive medical procedures in the world, yet little has changed about how we do them: for centuries, it’... |
| 30.04.2024 | Vitestro Raises $22M in Funding | Vitestro, an Utrecht, The Netherlands-based autonomous blood drawing company, raised $22M in funding. The round was led by Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fun... |
| 30.04.2024 | Vitestro Secures $22M for Autonomous Blood Draw Device | What You Should Know: – Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood drawing device. – This b... |
Show more